ANDA 74256, held by Teva. Gemfibrozil.
As of Nov 13, 2026, ANDA 74256 (Gemfibrozil), held by Teva, was first approved by FDA on Oct 31, 1993, with 21 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 31, 1993 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Gemfibrozil600MG · tablet;oral | Gemfibrozil | Discontinued |
| Sep 18, 2017 | Supplement 43Labeling · Standard review | Approved | None posted |
| Oct 3, 2016 | Supplement 41Labeling · Standard review | Approved | None posted |
| Apr 29, 2015 | Supplement 39Labeling · Standard review | Approved | None posted |
| Apr 29, 2015 | Supplement 38Labeling · Standard review | Approved | None posted |
| Feb 28, 2011 | Supplement 32Labeling | Approved | None posted |
| Jan 12, 2010 | Supplement 31Labeling | Approved | None posted |
| Mar 26, 2009 | Supplement 28Labeling | Approved | None posted |
| Jan 6, 2005 | Supplement 24Labeling | Approved | None posted |
| Apr 11, 2002 | Supplement 19Labeling | Approved | None posted |
| Jul 7, 2000 | Supplement 15Manufacturing | Approved | None posted |
| Jan 10, 2000 | Supplement 16Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 17Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 8Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 7Manufacturing | Approved | None posted |
| Jan 8, 1999 | Supplement 6Manufacturing | Approved | None posted |
| May 28, 1998 | Supplement 5Manufacturing | Approved | None posted |
| Nov 7, 1997 | Supplement 4Manufacturing | Approved | None posted |
| Dec 18, 1996 | Supplement 3Manufacturing | Approved | None posted |
| Sep 13, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Feb 28, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Oct 31, 1993 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters